Side-by-side comparison of AI visibility scores, market position, and capabilities
Norwalk CT online travel (NASDAQ: BKNG) at $23.74B 2024 revenue (+11%), $166B gross bookings; $20B buyback authorized Jan 2025, 10% dividend increase, Booking.com dominant in European accommodations competing with Expedia and Airbnb.
Booking Holdings Inc. is a Norwalk, Connecticut-based online travel platform — publicly traded on NASDAQ (NASDAQ: BKNG) as an S&P 500 Consumer Discretionary component — operating the world's largest portfolio of online travel brands including Booking.com (global accommodations leader), Priceline (US discount travel), Agoda (Asia-Pacific travel), KAYAK (metasearch), OpenTable (restaurant reservations), and Rentalcars.com across 220+ countries and territories through approximately 24,800 employees. In fiscal year 2024, Booking Holdings reported $23.74 billion in revenue (up 11% year-over-year), $5.88 billion in net income, and $166 billion in gross bookings — with Q4 2024 room nights growing 13% and gross bookings up 17% year-over-year. The company maintains a market capitalization exceeding $167 billion as of 2025. In January 2025, Booking Holdings authorized a $20 billion stock repurchase program and increased its quarterly dividend 10% to $9.60 per share, reflecting strong free cash flow generation. CEO Glenn Fogel has led the company since 2017, overseeing both pandemic recovery and the subsequent travel demand surge. Booking.com's accommodation inventory of millions of properties (hotels, vacation rentals, apartments, villas) across 220+ countries represents the broadest accommodation distribution platform in the global travel market.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.